Marit Dahl Solbu
Error rendering component
Research interests
- Chronic kidney disease (CKD), hypertension and metabolic syndrome in the general population - incidence/prevalence, risk factors, biomarkers and consequences (The Tromsø Study and other cohorts)
- The acute to chronic kidney disease (AKI/AKD to CKD) transition - incidence, risk factors and follow-up with patients with AKI/AKD
- Geographic inequalities in access to care among patients with kidney disease - in Norway and globally
- Clinical studies and trials: focus on increasing the number of patients with kidney disease included in clinical studies and trials. SGLT2 inhibitors in patients on kidney replacement therapy. Drug adherence in patients with hypertension. Renoprotective treatment in early CKD stages.
